Kemal Malik is on the board of Syncona Ltd. and Our Future Health Uk and Member of The Royal College of Physicians.

Dr. Malik previously occupied the position of Head-Innovation at Bayer AG Director & Chief Medical Officer-Pharmaceuticals at Bayer HealthCare AG and Chief Medical Officer & Head-Global Development at Bayer Pharma AG (both are subsidiaries of Bayer AG), Principal at Northwick Park Institute For Medical Research and Head-Medical Affairs & Clinical development at Bristol-Myers Squibb Pharmaceuticals Ltd.

He received an undergraduate degree from the University of London.